Related Experiment Video
Updated: Aug 6, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
A Novel Chronic Kidney Disease Phenotyping Algorithm Using Combined Electronic Health Record and Claims Data
Omar Mansour1, Julie M Paik1,2,3, Richard Wyss1
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Researchers developed a claims-based model to predict chronic kidney disease (CKD) stages using electronic health records. This tool aids studies lacking lab data, improving CKD phenotyping in claims.
Area of Science:
- Nephrology
- Health Informatics
- Biostatistics
Background:
- Chronic kidney disease (CKD) is frequently under-coded in healthcare claims data.
- Accurate CKD phenotyping is crucial for research and clinical applications.
- Electronic health records (EHRs) contain valuable laboratory data for CKD assessment.
Purpose of the Study:
- To develop and validate prediction models using claims data to identify CKD phenotypes.
- To overcome limitations of under-coding in claims data for CKD diagnosis.
- To enable robust CKD phenotyping without direct access to laboratory results.
Main Methods:
- Linked EHR data with Medicare claims for training and validation cohorts.
- Included individuals aged ≥65 with serum creatinine in EHRs (2007-2017).
- Utilized LASSO regression to predict estimated glomerular filtration rate (eGFR) categories (<60, <45, <30 mL/min/1.73m²).
Main Results:
- The validation cohort included 56,744 patients.
- The model achieved high Area Under the Curve (AUC) values: 0.81 for eGFR <60, 0.88 for eGFR <45, and 0.92 for eGFR <30 mL/min/1.73m².
- Positive predictive values ranged from 0.38 to 0.80 for the respective eGFR categories.
Conclusions:
- A claims-based prediction model for CKD stages defined by eGFR was successfully developed.
- This model serves as a valuable proxy for clinical endpoints and confounders in research.
- Facilitates enhanced subgroup effect assessment in studies lacking direct laboratory data.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction

